Table 5.
Full Specification: Final Logistic Model.
| i | Variable (Vi) | Coefficient (Ci) | Std. Error | Odds Ratio (95% CI) |
|---|---|---|---|---|
| Intercept | −2.7551480 | |||
| 1 | Age | −0.0379528 | 0.00663 | |
| 2 | Age2 | 6.15945E-04 | 0.00014 | |
| 3 | Age3 | −1.04739E-06 | 8.77732E-07 | |
| Gender | ||||
| 4 | Female | 0.2216384 | 0.01588 | 1.248 (1.210,1.288) |
| Ethnicity | ||||
| 5 | Indigenous Australian | 0.4033629 | 0.07675 | 1.497 (1.288,1.740) |
| 6 | Unknown | −0.0662497 | 0.01660 | 0.936 (0.906,0.967) |
| BMI | ||||
| 7 | [25, 30) | 0.0329420 | 0.02884 | 1.033 (0.977,1.094) |
| 8 | [30, 35) | 0.1939825 | 0.03225 | 1.214 (1.140,1.293) |
| 9 | [35, 40) | 0.2712273 | 0.04200 | 1.312 (1.208,1.424) |
| 10 | 40+ | 0.4643618 | 0.04627 | 1.591 (1.453,1.742) |
| 11 | Not recorded | 0.1395070 | 0.02198 | 1.150 (1.101,1.200) |
| Smoking Status | ||||
| 12 | Ex smoker | 0.1969316 | 0.01761 | 1.218 (1.176,1.260) |
| 13 | Smoker | 0.4057213 | 0.01636 | 1.500 (1.453,1.549) |
| 14 | Unknown | 0.1993470 | 0.02421 | 1.221 (1.164,1.280) |
| AnyAlcohol | ||||
| 15 | Drinker | −0.2853232 | 0.03423 | 0.752 (0.703,0.804) |
| 16 | Not recorded | −0.2301394 | 0.04245 | 0.794 (0.731,0.863) |
| SEIFA IRSAD | ||||
| 17 | 1 | −0.0123849 | 0.02505 | 0.988 (0.940,1.037) |
| 18 | 2 | −0.0742180 | 0.05930 | 0.928 (0.827,1.043) |
| 19 | 3 | 0.0044308 | 0.03370 | 1.004 (0.940,1.073) |
| 20 | 4 | −0.1857272 | 0.02472 | 0.831 (0.791,0.872) |
| 21 | 6 | −0.2340966 | 0.02585 | 0.791 (0.752,0.832) |
| 22 | 7 | −0.2468854 | 0.02507 | 0.781 (0.744,0.821) |
| 26 | 8 | −0.2990624 | 0.02832 | 0.742 (0.701,0.784) |
| 24 | 9 | −0.1834029 | 0.02176 | 0.832 (0.798,0.869) |
| 25 | 10 | −0.4622169 | 0.02792 | 0.630 (0.596,0.665) |
| 26 | Unknown | −0.0301620 | 0.13850 | 0.970 (0.740,1.273) |
| Medications | ||||
| 27 | Statins | −0.0152881 | 0.02606 | 0.985 (0.936,1.036) |
| 28 | AntiCoagulants | 0.2886091 | 0.04044 | 1.335 (1.233,1.445) |
| 29 | AntiDepressants | 0.2025163 | 0.03020 | 1.224 (1.154,1.299) |
| 30 | AntiPsychotics | 0.3923084 | 0.03527 | 1.480 (1.382,1.586) |
| 31 | AntiInflammatories | 0.1301034 | 0.01442 | 1.139 (1.107,1.172) |
| 32 | Steroids | 0.1488350 | 0.01800 | 1.160 (1.120,1.202) |
| Number of Diagnosis Families | ||||
| 33 | Num. Diagnosis Families | 0.3369661 | 0.03298 | |
| 34 | (Num. Diagnosis Families)2 | −0.0397663 | 0.00653 | |
| 35 | (Num. Diagnosis Families)3 | 0.0019304 | 0.00057 | |
| Diagnosis Groups | ||||
| 36 | Respiratory | −0.0715037 | 0.04264 | 0.931 (0.856,1.012) |
| 37 | Atrial Fibrillation | 0.2234789 | 0.05779 | 1.250 (1.117,1.400) |
| 38 | Cardiovascular | 0.4764327 | 0.04877 | 1.610 (1.464,1.772) |
| 39 | Osteoarthritis | −0.2060183 | 0.03764 | 0.814 (0.756,0.876) |
| 40 | Osteoporosis | 0.0595034 | 0.08957 | 1.061 (0.890,1.265) |
| 41 | Rheumatoid Arthritis | 0.1149149 | 0.07502 | 1.122 (0.968,1.299) |
| 42 | Mental Health | 0.0686955 | 0.04483 | 1.071 (0.981,1.169) |
| 43 | Cancer | 0.0600825 | 0.04073 | 1.062 (0.980,1.150) |
| 44 | Digestive Diseases | 0.1796635 | 0.03992 | 1.197 (1.107,1.294) |
| 45 | Hypertension | −0.1591489 | 0.04100 | 0.853 (0.787,0.924) |
| 46 | Bloodfats | −0.3726723 | 0.03771 | 0.689 (0.640,0.742) |
| 47 | Chronic Kidney Disease | 0.0268266 | 0.08500 | 1.027 (0.870,1.213) |
| 48 | Diabetes (type 1) | 0.5844975 | 0.10630 | 1.794 (1.457,2.210) |
| 49 | Diabetes type 2) | 0.1332004 | 0.04722 | 1.142 (1.041,1.253) |
| 50 | Venous Thromboembolism | 0.3623621 | 0.06477 | 1.437 (1.265,1.631) |
| 51 | Other Conditions | 0.5157983 | 0.08211 | 1.675 (1.426,1.967) |
| Pathology Test Results | ||||
| Haemoglobin (g/L) | ||||
| 52 | High (<100) | 0.4416708 | 0.06741 | 1.555 (1.363,1.775) |
| 53 | Med (M:100–130, F: 100–120) | 0.1546069 | 0.02639 | 1.167 (1.108,1.229) |
| 54 | No test history | 0.0450222 | 0.17061 | 1.046 (0.749,1.461) |
| Platelets (per L) | ||||
| 55 | High (>480 × 1e9) | 0.1398411 | 0.08950 | 1.150 (0.965,1.371) |
| 56 | No test history | −0.0147097 | 0.17048 | 0.985 (0.706,1.376) |
| Alanine aminotransferase level (u/L) | ||||
| 57 | High (M: >120, F: >90) | −0.0619518 | 0.09056 | 0.940 (0.787,1.122) |
| 58 | Med (M: 80–120, F: 60–90) | 0.0550267 | 0.06484 | 1.057 (0.930,1.200) |
| 29 | No test history | −0.2940664 | 0.24315 | 0.745 (0.463,1.200) |
| Gamma-glutamyl transferase (u/L) | ||||
| 60 | High (M: >150, F: >105) | 0.2209109 | 0.04884 | 1.247 (1.133,1.372) |
| 61 | Med (M: 100–150, F 70–105) | 0.1261477 | 0.04895 | 1.134 (1.031,1.249) |
| 62 | No test history | 0.1979201 | 0.21908 | 1.219 (0.793,1.873) |
| Haemoglobin A1c level (mmol/mol) | ||||
| 63 | High (〉〉69.4) | 0.1746667 | 0.04153 | 1.191 (1.098,1.292) |
| 64 | Med (58.5–69.4) | 0.1720256 | 0.05061 | 1.188 (1.076,1.312) |
| 65 | No test history | −0.0461721 | 0.01882 | 0.955 (0.920,0.991) |
| Total cholesterol (mmol/L) | ||||
| 66 | High (>7.5) | 0.0453054 | 0.07726 | 1.046 (0.899,1.217) |
| 67 | Med (6.5–7.5) | −0.0363534 | 0.04640 | 0.964 (0.880,1.056) |
| 68 | No test history | 0.1749709 | 0.15300 | 1.191 (0.883,1.608) |
| Albumin/creatinine ratio (mg/mmol) | ||||
| 69 | High (>30) | 0.3042750 | 0.08592 | 1.356 (1.146,1.604) |
| 70 | Med (3–30) | 0.1151562 | 0.05232 | 1.122 (1.013,1.243) |
| 71 | No test history | 0.1059512 | 0.02951 | 1.112 (1.049,1.178) |
| LDL cholesterol (mmol/L) | ||||
| 72 | High (>4) | −0.0585925 | 0.03821 | 0.943 (0.875,1.016) |
| 73 | Med (3–4) | −0.0539600 | 0.02062 | 0.947 (0.910,0.987) |
| 74 | No test history | 0.1556545 | 0.05693 | 1.168 (1.045,1.306) |
| Estimated glomerular filtration rate (ml/min) | ||||
| 75 | High (<30) | 0.0891486 | 0.07968 | 1.093 (0.935,1.278) |
| 76 | Med (30–45) | 0.0950474 | 0.05205 | 1.100 (0.993,1.218) |
| 77 | No test history | 0.0459790 | 0.02027 | 1.047 (1.006,1.089) |
| Blood pressure | ||||
| 78 | High (systolic >160 and diastolic >100) | 0.2946162 | 0.10197 | 1.343 (1.099,1.640) |
| 79 | Med (systolic: 140–160 AND diastolic: 90–100) | 0.1839175 | 0.03706 | 1.202 (1.118,1.292) |
| 80 | No test history | 0.0112105 | 0.01543 | 1.011 (0.981,1.042) |
| Bilirubin (umol/L) | ||||
| 81 | Med_or_High (>40) | 0.1803894 | 0.15242 | 1.198 (0.888,1.615) |
| 82 | No test history | 0.0784321 | 0.21276 | 1.082 (0.713,1.641) |
| Creatinine (umol/L) | ||||
| 83 | Med_or_High (M: >350, F: >300) | 1.1349460 | 0.15125 | 3.111 (2.313,4.185) |
| 84 | No test history | −0.1704331 | 0.02109 | 0.843 (0.809,0.879) |
| Triglycerides (mmol/L) | ||||
| 85 | Med_or_High (>4) | 0.1234874 | 0.05878 | 1.131 (1.008,1.270) |
| 86 | No test history | −0.0963018 | 0.16070 | 0.908 (0.663,1.244) |
| Gender-Diagnosis Group Interactions Terms | ||||
| 87 | Gender × Respiratory | 0.0570566 | 0.04067 | 1.059 (0.978,1.147) |
| 88 | Gender × Cardiovascular | −0.2108839 | 0.05868 | 0.810 (0.722,0.909) |
| 89 | Gender × Osteoporosis | −0.2475655 | 0.09695 | 0.781 (0.646,0.944) |
| 90 | Gender × Mental health | −0.0643675 | 0.03514 | 0.938 (0.875,1.005) |
| 91 | Gender × Hypertension | −0.0890935 | 0.04019 | 0.915 (0.845,0.990) |
| 92 | Gender × Chronic Kidney disease | −0.1122160 | 0.10963 | 0.894 (0.721,1.108) |
| 93 | Gender × Diabetes (type 1) | 0.2492323 | 0.14198 | 1.283 (0.971,1.695) |
| 94 | Gender × Diabetes (type 2) | −0.0002784 | 0.05227 | 1.000 (0.902,1.108) |
| 95 | Gender × Other Conditions | −0.1721620 | 0.10383 | 0.842 (0.687,1.032) |
Note: Coefficients for Age2 and Age3 are shown using scientific notation to provide additional precision.